Search

Author/Creator Dechant, Michael

1. An IgG3 switch variant of rituximab mediates enhanced complement‐dependent cytotoxicity against tumour cells with low CD20 expression levels. (7th January 2013)

Authors:
Rösner, Thies; Derer, Stefanie; Kellner, Christian; Dechant, Michael; Lohse, Stefan; Vidarsson, Gestur; Peipp, Matthias; Valerius, Thomas
Journal:
British journal of haematology
Issue:
Volume 161:Number 2(2013:Apr.)
Page Start:
282
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity. (27th April 2017)

Authors:
Lohse, Stefan; Loew, Sebastian; Kretschmer, Anna; Jansen, J. H. Marco; Meyer, Saskia; ten Broeke, Toine; Rösner, Thies; Dechant, Michael; Derer, Stefanie; Klausz, Katja; Kellner, Christian; Schwanbeck, Ralf; French, Ruth R.; Tipton, Thomas R. W.; Cragg, Mark S.; Schewe, Denis M.; Peipp, Matthias;...
Journal:
British journal of haematology
Issue:
Volume 181:Number 3(2018)
Page Start:
413
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. IgA EGFR antibodies mediate tumour killing in vivo. Issue 8 (5th August 2013)

Authors:
Boross, Peter; Lohse, Stefan; Nederend, Maaike; Jansen, Johannes Hendrik Marco; van Tetering, Geert; Dechant, Michael; Peipp, Matthias; Royle, Louise; Liew, Li Phing; Boon, Louis; van Rooijen, Nico; Bleeker, Wim K.; Parren, Paul W. H. I.; van de Winkel, Jan G. J.; Valerius, Thomas; Leusen, Jeanet...
Journal:
EMBO molecular medicine
Issue:
Volume 5:Issue 8(2013:Aug.)
Page Start:
1213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗